ERIS LIFESCIENCES
Back to Balance Sheet
|
ERIS LIFESCIENCES Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹2,609 Cr | ₹521 Cr | ₹283 Cr | ₹235 Cr | ₹220 Cr |
What is the latest Total Current Liabilities ratio of ERIS LIFESCIENCES ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹2,609 Cr |
Mar2023 | ₹521 Cr |
Mar2022 | ₹283 Cr |
Mar2021 | ₹235 Cr |
Mar2020 | ₹220 Cr |
How is Total Current Liabilities of ERIS LIFESCIENCES Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹2,609 Cr | 400.58 | |
Mar2023 | ₹521 Cr | 83.94 | |
Mar2022 | ₹283 Cr | 20.34 | |
Mar2021 | ₹235 Cr | 6.94 | |
Mar2020 | ₹220 Cr | - |
Compare Total Current Liabilities of peers of ERIS LIFESCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ERIS LIFESCIENCES | ₹19,962.5 Cr | 7.4% | 13.4% | 55.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹419,764.0 Cr | -1.6% | -6% | 46.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,306.0 Cr | 0.4% | 3.9% | 64% | Stock Analytics | |
CIPLA | ₹120,459.0 Cr | 1.8% | 0.2% | 17.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,168.0 Cr | 0.5% | -7.9% | 6.7% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,662.7 Cr | 0.7% | -4% | 48.3% | Stock Analytics |
ERIS LIFESCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ERIS LIFESCIENCES | 7.4% |
13.4% |
55.8% |
SENSEX | 3.4% |
0.2% |
21.7% |
You may also like the below Video Courses